Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Chen Yu reported a 6.70% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Chen Yu reported a 6.70% stake in Vistagen Therapeutics, Inc., 2,960,404 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 2,960,404
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP I, LLC | 1.80% | 740,101 |
| TCG Crossover Fund I, L.P. | 1.80% | 740,101 |
| TCG Crossover GP II, LLC | 5.10% | 2,220,303 |
| TCG Crossover Fund II, L.P. | 5.10% | 2,220,303 |
| Chen Yu | 6.70% | 2,960,404 |
Source
Related
- Vistagen Therapeutics, Inc.
- TCG Crossover GP I, LLC
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026
- Form 4 · Singh Shawn · Jul 2, 2026